Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Net Margin (2020 - 2025)

Rapid Micro Biosystems' Net Margin history spans 6 years, with the latest figure at 110.77% for Q4 2025.

  • On a quarterly basis, Net Margin rose 685.0% to 110.77% in Q4 2025 year-over-year; TTM through Dec 2025 was 140.3%, a 2685.0% increase, with the full-year FY2025 number at 140.3%, up 2685.0% from a year prior.
  • Net Margin hit 110.77% in Q4 2025 for Rapid Micro Biosystems, up from 146.78% in the prior quarter.
  • Over the last five years, Net Margin for RPID hit a ceiling of 110.77% in Q4 2025 and a floor of 486.47% in Q1 2021.
  • Historically, Net Margin has averaged 249.98% across 5 years, with a median of 232.09% in 2021.
  • The widest YoY moves for Net Margin: up 20850bps in 2021, down -16158bps in 2021.
  • Tracing RPID's Net Margin over 5 years: stood at 280.43% in 2021, then crashed by -34bps to 376.02% in 2022, then surged by 53bps to 176.3% in 2023, then soared by 33bps to 117.62% in 2024, then increased by 6bps to 110.77% in 2025.
  • Business Quant data shows Net Margin for RPID at 110.77% in Q4 2025, 146.78% in Q3 2025, and 163.29% in Q2 2025.